Lupin gets USFDA nod for multiple sclerosis drug
The Hindu
Lupin receives USFDA approval for generic Siponimod Tablets to treat multiple sclerosis, boosting market presence and potential sales.
More Related News
Lupin receives USFDA approval for generic Siponimod Tablets to treat multiple sclerosis, boosting market presence and potential sales.